Avivagen Shares Owned By Insiders vs. EBITDA
| VIVXF Stock | USD 0.0001 0.00 0.00% |
For Avivagen profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Avivagen to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Avivagen utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Avivagen's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Avivagen over time as well as its relative position and ranking within its peers.
Avivagen |
Avivagen EBITDA vs. Shares Owned By Insiders Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Avivagen's current stock value. Our valuation model uses many indicators to compare Avivagen value to that of its competitors to determine the firm's financial worth. Avivagen is rated below average in shares owned by insiders category among its peers. It is rated below average in ebitda category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Avivagen's earnings, one of the primary drivers of an investment's value.Avivagen EBITDA vs. Shares Owned By Insiders
Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
Avivagen |
| = | 1.43 % |
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Avivagen |
| = | (4.68 M) |
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Avivagen EBITDA Comparison
Avivagen is currently under evaluation in ebitda category among its peers.
Avivagen Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Avivagen, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Avivagen will eventually generate negative long term returns. The profitability progress is the general direction of Avivagen's change in net profit over the period of time. It can combine multiple indicators of Avivagen, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Avivagen Inc., a life sciences company, focuses on developing and commercializing products for livestock feeds that support immune function and help animals to achieve their growth and productivity. Avivagen Inc. was incorporated in 2005 and is headquartered in Ottawa, Canada. Avivagen is traded on OTC Exchange in the United States.
Avivagen Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Avivagen. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Avivagen position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Avivagen's important profitability drivers and their relationship over time.
Use Avivagen in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Avivagen position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Avivagen will appreciate offsetting losses from the drop in the long position's value.Avivagen Pair Trading
Avivagen Pair Trading Analysis
The ability to find closely correlated positions to Avivagen could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Avivagen when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Avivagen - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Avivagen to buy it.
The correlation of Avivagen is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Avivagen moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Avivagen moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Avivagen can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Avivagen position
In addition to having Avivagen in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run SPAC Thematic Idea Now
SPAC
Entities that are involved in raising capital, merging with and acquiring companies, and investing in private equity through leveraged buyouts. The SPAC theme has 25 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize SPAC Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Avivagen Pink Sheet
To fully project Avivagen's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Avivagen at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Avivagen's income statement, its balance sheet, and the statement of cash flows.